Sun Pharma to acquire 9.6% stake in HaystackAnalytics

07 Jun 2024 Evaluate

Sun Pharmaceutical Industries has entered into an agreement with HaystackAnalytics (Haystack), pursuant to which Sun Pharma has agreed to acquire 9.6% of total outstanding securities. Cost of acquisition is Rs 33 crore. The said acquisition is expected to be completed by July 2024 subject to satisfactory completion of certain conditions. 

Haystack is engaged in the business of developing genomic analysis software that enables clinical decision-making through culturefree, comprehensive, and fast clinical genomics by automating bioinformatic analysis to produce clear and clinically relevant reports and utilization of the genomic data and their analysis for creation of new products for healthcare. 

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.


Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×